blackthorn.ai

blackthorn.ai, trading as Blackthorn AI, works where software engineering, AI, bioinformatics and scientific workflow design meet. Its current focus is helping teams building AI medical devices gather the evidence needed for FDA and MDR submissions, alongside data and AI builds for pharma and biotech companies.

What blackthorn.ai offers

• Medical AI evidence and validation — statistical analysis plans, model validation and change control written by researchers.
• OmicsLayer — turns messy multimodal biomarker data into reusable workflows for cohort selection and responder prediction.
• TrialLens and AssetLens — analysis of patient-level trial data, and estimates of development cost and commercial scenarios for drug assets.
• Drug discovery AI — AI-driven molecule generation and multi-omics analysis.
• Data engineering and MLOps — centralised data warehouses, automated ETL pipelines and automated model training.
• AI agents and automation — replacing manual data handling with structured pipelines.

Who it works with

Clients include biotech and pharma companies, digital health platforms and diagnostics firms such as Dalriada Drug Discovery and HealthWorks Dx. Past projects include a breast cancer detection platform using vision AI.

Key facts

• Leadership: Alex Gurbych, PhD, chief executive and chief solutions architect
• Team: engineers and scientists, several with doctorates
• Certifications: developers hold AWS, Google, Microsoft and Oracle certificates